GlassScriptPhysician profile
Asutosh S Gor
NPI 1407947757
$40,112.64
in general payments reported to CMS, 2019-2025
93 companies · $3,688 in 2025
The $3,688 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,227 · 2021: $4,927 · 2022: $4,135 · 2023: $6,279 · 2024: $4,254 · 2025: $3,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,418 · Education: $366 · Long Term Medical Supply Or Device Loan: $333 · Travel and Lodging: $20.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,083.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,417.50 |
| Education | $366.11 |
| Long Term Medical Supply Or Device Loan | $333.32 |
| Travel and Lodging | $20.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $5,169.74 | 2019-2025 | Tecentriq, Venclexta, Polivy |
| Secura Bio, INC. | $3,122.17 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $2,866.36 | 2019-2025 | |
| Genzyme Corporation | $2,277.11 | 2019-2025 | |
| Seagen INC. | $1,726.89 | 2019-2023 | Padcev, Adcetris |
| Heron Therapeutics, INC. | $1,695.82 | 2019-2020 | |
| Janssen Biotech, INC. | $1,516.16 | 2019-2025 | Erleada, Carvykti, Darzalex |
| Fresenius Kabi USA, LLC | $1,500.00 | 2021 | |
| Genmab U.S., INC. | $1,495.05 | 2023-2025 | Epkinly |
| Merck Sharp & Dohme LLC | $1,119.88 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| E.R. Squibb & Sons, L.L.C. | $1,070.86 | 2019-2025 | Opdivo, Reblozyl |
| Taiho Oncology, INC. | $996.09 | 2019-2025 | |
| Abbvie INC. | $912.45 | 2019-2025 | |
| Incyte Corporation | $909.40 | 2019-2025 | Jakafi, Pemazyre, Niktimvo |
| Pfizer INC. | $881.00 | 2019-2025 |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $787.32 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Amgen INC. | $608.84 | 2019-2023 | Vectibix, Nplate, Xgeva |
| Lilly USA, LLC | $560.99 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Daiichi Sankyo INC. | $529.90 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Glaxosmithkline, LLC. | $524.14 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Eisai INC. | $518.74 | 2019-2024 | |
| Pharmacosmos Therapeutics INC. | $495.78 | 2021-2025 | Monoferric, Cosela |
| Takeda Pharmaceuticals U.S.A., INC. | $484.96 | 2020-2024 | Alunbrig, Ninlaro, Iclusig |
| Astellas Pharma US INC | $480.63 | 2019-2025 | Xtandi, Padcev |
| Celgene Corporation | $426.76 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Exelixis INC. | $388.99 | 2019-2024 | Cabometyx |
| Asd Specialty Healthcare, LLC | $379.28 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $371.92 | 2021-2025 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $345.92 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $312.85 | 2020-2025 | Xpovio |
| Gilead Sciences, INC. | $288.35 | 2019-2025 | Trodelvy |
| Kite Pharma, INC. | $281.03 | 2020-2024 | Yescarta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $278.93 | 2019-2025 | Gilotrif |
| Array Biopharma INC | $272.09 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Cti Biopharma Corp. | $269.71 | 2022-2023 | Vonjo |
| Adaptive Biotechnologies Corporation | $223.46 | 2022-2025 | Clonoseq |
| Sun Pharmaceutical Industries INC. | $210.43 | 2021-2024 | |
| Puma Biotechnology, INC. | $199.06 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $183.82 | 2019-2025 | Soliris, Ultomiris |
| Foundation Medicine, INC. | $182.84 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $174.16 | 2019-2023 | Imbruvica |
| Servier Pharmaceuticals LLC | $166.50 | 2022-2025 | |
| Sobi, INC | $166.14 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $165.08 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $160.15 | 2019-2025 | Tavalisse, Rezlidhia, Gavreto |
| Deciphera Pharmaceuticals INC. | $141.72 | 2022-2025 | Qinlock, Romvimza |
| Coherus Oncology, INC. | $141.71 | 2020-2023 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2021 | |
| Tg Therapeutics, INC. | $118.33 | 2022 | |
| Aveo Pharmaceuticals, INC. | $103.81 | 2022-2024 | |
| Beigene USA, INC. | $99.90 | 2021-2023 | Brukinsa |
| Emd Serono, INC. | $94.15 | 2023-2025 | Bavencio |
| Oxford Gene Technology INC | $93.61 | 2023 | |
| Sandoz INC. | $86.12 | 2024-2025 | Cyclophosphamide, Ziextenzo |
| Ipsen Biopharmaceuticals, INC | $83.41 | 2019-2021 | |
| Adc Therapeutics America, INC. | $78.89 | 2022-2025 | |
| Acrotech Biopharma INC. | $74.67 | 2022-2025 | Beleodaq |
| Tersera Therapeutics LLC | $64.54 | 2025 | Xermelo, Quzyttir |
| Dova Pharmaceuticals | $63.64 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $63.31 | 2020-2022 | |
| Novocure INC. | $53.34 | 2023-2024 | Optune |
| Kyowa Kirin, INC. | $50.66 | 2022-2025 | Poteligeo |
| Spectrum Pharmaceuticals INC. | $49.79 | 2023-2025 | Rolvedon |
| Tolmar Pharmaceuticals, INC. | $48.39 | 2019-2022 | |
| Legend Biotech USA INC. | $47.99 | 2025 | Carvykti |
| Mirati Therapeutics, INC. | $46.57 | 2023 | Krazati |
| Octapharma USA, INC. | $46.39 | 2019 | |
| Fennec Pharmaceuticals, INC. | $45.49 | 2024 | Pedmark |
| Eusa Pharma (US) LLC | $44.18 | 2022 | |
| Agios Pharmaceuticals, INC. | $38.46 | 2019-2021 | |
| Csl Behring | $37.22 | 2024 | Hemgenix |
| Celltrion USA INC. | $36.57 | 2024 | Vegzelma |
| Mylan Institutional INC. | $33.49 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.13 | 2019-2021 | |
| Stemline Therapeutics INC. | $31.67 | 2025 | Elzonris, Orserdu |
| Shire North American Group INC | $29.95 | 2019 | |
| Cycle Pharmaceuticals INC | $26.39 | 2025 | Phyrago |
| Geron Corporation | $24.88 | 2025 | Rytelo |
| Springworks Therapeutics, INC. | $24.48 | 2025 | Gomekli |
| G1 Therapeutics, INC. | $24.39 | 2022 | |
| Pharmaessentia USA Corporation | $21.33 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.93 | 2025 | Danziten |
| Tempus Ai, INC | $18.98 | 2025 | Xt Cdx |
| Organon LLC | $18.83 | 2022 | |
| Amneal Pharmaceuticals LLC | $18.35 | 2025 | Alymsys |
| Epizyme, INC. | $16.99 | 2022 | |
| Advanced Accelerator Applications | $16.32 | 2020 | |
| Immunocore Limited | $15.20 | 2024 | Kimmtrak |
| Myriad Genetic Laboratories, INC. | $14.44 | 2024 | Myrisk |
| Lexicon Pharmaceuticals, INC. | $14.04 | 2019 | |
| Verastem, INC. | $12.33 | 2019 | |
| Morphosys, US INC. | $11.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $10.47 | 2023 | Xarelto |
Drugs and devices associated with these payments
Epkinly $1,638Kisqali $765Imbruvica $448Monoferric $446Keytruda $426Jakafi $377Lonsurf $366Inqovi $366Vonjo $320Venclexta $305Reblozyl $287Opdivo $280Verzenio $271Jaypirca $266Braftovi $258Erleada $251Piqray $250Libtayo $243Padcev $235Carvykti $221Mektovi $208Tecentriq $206Tukysa $201Ibrance $191Clonoseq $191Enhertu $185Ojjaara $182Lorbrena $174Scemblix $169Alunbrig $160Darzalex $158Sarclisa $155Rybrevant $146Lenvima $140Nubeqa $136Bosulif $130Xpovio $128Jemperli $127Polivy $120Qinlock $120Xtandi $117Zejula $107Calquence $105Pluvicto $98.47Adcetris $97.46Besponsa $96.88Lynparza $96.38Elrexfio $94.12Lutathera $92.99Tavalisse $88.59Cabometyx $88.03Soliris $85.00Doptelet $84.91Talvey $84.18Tasigna $81.59Xofigo $80.25Imfinzi $73.15Tibsovo $69.29Emrelis $67.27Ultomiris $64.33Nerlynx $64.08Fabhalta $61.99Tecvayli $61.02Cyclophosphamide $56.86Gilotrif $56.19Nplate $55.34Xgeva $55.34Vectibix $55.34Optune $53.34Romvimza $51.72Lunsumio $51.68Beleodaq $51.26Rolvedon $49.79Krazati $46.57Alecensa $46.10Pedmark $45.49Ninlaro $44.95Rezlidhia $42.89Zynlonta $42.81Lupron Depot $42.46Comirnaty $42.22Trodelvy $41.78Pemazyre $41.40Phesgo $41.06Inlyta $40.95Talzenna $40.93Balversa $40.86Akeega $40.86Pomalyst $40.54Bavencio $40.46Voranigo $39.98Opdualag $38.34Yescarta $37.66Hemgenix $37.22Vegzelma $36.57Paxlovid $34.83Poteligeo $34.81Iclusig $34.54Xermelo $34.14Retevmo $33.12
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asutosh Gor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.